Aspherical lenses = less aberrations

Article

The incidence of spherical aberrations tends to be lower in eyes with aspherical lenses than in eyes with spherical lenses.

The incidence of spherical aberrations tends to be lower in eyes with aspherical lenses than in eyes with spherical lenses, according to Paolo Garimoldi and colleagues from the Ospedale di Circolo, Italy.

A total of 42 eyes affected by cataract underwent phacoemulsification and implantation of an intraocular lens (IOL) in the capsular bag. Subjects were randomized to receive one of three types of aspherical lenses: Alcon Acrysof IQ, Bausch and Lomb ADAPT, Ligi AS/60, or one type of spherical lens: Hoya AF 1. All eyes, including the control group of 12 young healthy eyes, underwent corneal topography and aberrometry 15 days prior to surgery.

Fifteen days following surgery, the mean total spherical aberration was significantly higher in eyes with a spherical lens. Among the aspherical lenses only small differences were noted. The mean corneal spherical aberration was similar in all groups, however the mean internal spherical aberration was higher in eyes that received the spherical lens.

Dr Garimoldi concluded that spherical aberrations are less common in eyes implanted with aspherical lenses.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.